These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22569604)

  • 1. Does nesiritide reduce mortality and readmission in decompensated heart failure?
    Bernardo WM; Moreira FT
    Rev Assoc Med Bras (1992); 2012; 58(2):133-4. PubMed ID: 22569604
    [No Abstract]   [Full Text] [Related]  

  • 2. [Does nesiritide reduce dyspnea in decompensated heart failure?].
    Bernardo WM; Moreira FT
    Rev Assoc Med Bras (1992); 2012; 58(1):11-3. PubMed ID: 22392308
    [No Abstract]   [Full Text] [Related]  

  • 3. Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment.
    Munger MA; Ng TM; Van Tassell BW
    Pharmacotherapy; 2007 May; 27(5):619-25. PubMed ID: 17461695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nesiritide in acute decompensated heart failure: to use or not to use, that is the question?
    Kapoor JR
    Am J Cardiol; 2007 Aug; 100(4):745-6. PubMed ID: 17697845
    [No Abstract]   [Full Text] [Related]  

  • 5. Nesiritide for acute decompensated heart failure.
    Alhosaini H
    Am Fam Physician; 2006 Oct; 74(8):1279; author reply 1279-80. PubMed ID: 17087421
    [No Abstract]   [Full Text] [Related]  

  • 6. The ASCEND-HF trial: an acute study of clinical effectiveness of nesiritide and decompensated heart failure.
    Dandamudi S; Chen HH
    Expert Rev Cardiovasc Ther; 2012 May; 10(5):557-63. PubMed ID: 22651831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nesiritide is beneficial or harmful to patients with decompensated acute congestive heart failure.
    Ma X; Sun F; Ma J
    Int J Cardiol; 2015; 187():387-8. PubMed ID: 25841132
    [No Abstract]   [Full Text] [Related]  

  • 8. Outcomes associated with nesiritide administration for acute decompensated heart failure in the emergency department observation unit: a single center experience.
    Styron JF; Jois-Bilowich P; Tallman T; Emerman C; Starling RC; Frank Peacock W
    Congest Heart Fail; 2009; 15(3):103-7. PubMed ID: 19522957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nesiritide in heart failure: commercial success or therapeutic advance?].
    Stampfli T; Perrier A
    Rev Med Suisse; 2006 Jan; 2(50):295-8. PubMed ID: 16503047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of death associated with nesiritide in patients with acutely decompensated heart failure.
    Aaronson KD; Sackner-Bernstein J
    JAMA; 2006 Sep; 296(12):1465-6. PubMed ID: 17003394
    [No Abstract]   [Full Text] [Related]  

  • 11. Controversy and conflict in the treatment of acute decompensated heart failure: limited role for nesiritide.
    Noviasky JA
    Pharmacotherapy; 2007 May; 27(5):626-32. PubMed ID: 17461696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nesiritide--not verified.
    Schreiner G
    N Engl J Med; 2005 Oct; 353(14):1525-7; author reply 1525-7. PubMed ID: 16211709
    [No Abstract]   [Full Text] [Related]  

  • 13. Nesiritide in acute decompensated heart failure.
    Kramer DB
    N Engl J Med; 2011 Oct; 365(16):1547; discussion 1547. PubMed ID: 22010930
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of nesiritide in patients with acute decompensated heart failure.
    DeWald TA; Hernandez AF
    Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):159-69. PubMed ID: 20136602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-type natriuretic peptides in management of acute decompensated heart failure.
    Yancy CW
    Heart Fail Clin; 2006 Jul; 2(3):353-64. PubMed ID: 17386904
    [No Abstract]   [Full Text] [Related]  

  • 16. Nesiritide for the treatment of decompensated heart failure.
    Wylie JV; Tsao L
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):803-13. PubMed ID: 15500426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal subanalysis of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF): the end of nesiritide as a cardiorenal therapeutic?
    Testani JM
    Circulation; 2014 Sep; 130(12):936-8. PubMed ID: 25074508
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of recombinant human B-type natriuretic peptide (nesiritide) in the management of acute decompensated heart failure.
    Strain WD
    Int J Clin Pract; 2004 Nov; 58(11):1081-7. PubMed ID: 15605677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nesiritide: harmful or harmless?
    Dorsch MP; Rodgers JE
    Pharmacotherapy; 2006 Oct; 26(10):1465-78. PubMed ID: 16999657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of nesiritide on renal function and mortality in patients suffering from heart failure.
    Dontas ID; Xanthos T; Dontas I; Lelovas P; Papadimitriou L
    Cardiovasc Drugs Ther; 2009 Jun; 23(3):221-33. PubMed ID: 19252976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.